Amphastar (AMPH) | Stock Overview & Key Data
Amphastar Performance Comparison
Stock Range
Today's Range
Low: $20.39
High: $21.25
on August 1, 2025
52 Week Range
Low: $20.39
High: $53.96
on August 1, 2025
on November 6, 2024
All-Time High: $67.66 on August 7, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$999.8M
EPS
2.76
P/E Ratio (TTM)
7.68
Forward P/E
4.85
P/B Ratio
1.35
PEG Ratio
4.85
Div. Yield
N/A
ROE
19.90%
Beta
0.718
Debt to Equity
86.86
Financial Highlights
Profitability
Gross Margin
49.99%
Operating Margin
21.87%
Profit Margin
19.38%
Returns and Earnings
Return on Assets (TTM)
7.60%
Return on Equity (TTM)
19.90%
EBITDA
$259.2M
Net Income (TTM)
$141.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$15.34
Quarterly Revenue Growth (YoY)
-0.80%
Quarterly Earnings Growth (YoY)
-41.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Amphastar AMPH | 999.82M Small-cap | -5.19% | -9.13% | -11.18% | -36.48% | -41.67% | -48.98% | -42.30% | 5.31% |
| Zoetis ZTS | 67.73B Large-cap | -3.12% | -7.42% | -5.31% | -14.28% | -9.37% | -18.39% | -15.59% | -7.24% |
| Haleon Plc - ADR HLN | 43.39B Large-cap | -2.23% | -6.67% | -6.49% | 1.90% | 2.33% | 0.31% | 29.32% | 30.36% |
| Supernus SUPN | 1.99B Small-cap | 5.75% | 11.60% | 9.43% | -4.95% | -2.53% | 23.38% | 10.42% | 53.86% |
| BGM BGM | 1.73B Small-cap | -17.70% | -16.67% | -23.89% | -14.00% | -3.80% | 43.09% | 18.62% | -80.34% |
| BioCryst BCRX | 1.66B Small-cap | -7.02% | -11.67% | -8.73% | 4.33% | 1.53% | 13.25% | -43.42% | 100.25% |
Ownership & Short Interest
Insider Ownership
23.69%
Institutional Ownership
72.85%
Shares Short
4M
Short Ratio
7.91
Short % of Shares Outstanding
16.84%
Average 10-Day Volume
428K
Average 90-Day Volume
492K
Amphastar Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Amphastar would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AMPH's 52-week high and low?
- In the last 52 weeks, Amphastar reached a high of $53.96 (on November 6, 2024) and a low of $20.39 (on August 1, 2025).
- What is the market cap and P/E ratio for AMPH?
- Curious about Amphastar's size and valuation? Its market capitalization stands at 999.82M. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.68, and the forward P/E (looking ahead) is 4.85.
- Does AMPH pay dividends? If so, what's the yield?
- As for dividends, Amphastar isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Amphastar's main competitors or similar companies to consider before investing?
When looking at Amphastar, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS67.73B Healthcare Drug Manufacturers - Specialty & Generic -18.39% -15.59% Haleon Plc - ADR
HLN43.39B Healthcare Drug Manufacturers - Specialty & Generic 0.31% 29.32% Supernus
SUPN1.99B Healthcare Drug Manufacturers - Specialty & Generic 23.38% 10.42% BGM
BGM1.73B Healthcare Drug Manufacturers - Specialty & Generic 43.09% 18.62% BioCryst
BCRX1.66B Healthcare Drug Manufacturers - Specialty & Generic 13.25% -43.42% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Amphastar Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Amphastar's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.90%, the Debt to Equity ratio from the most recent quarter is 86.86, and its Gross Profit Margin stands at 49.99%.
- What is the recent revenue and earnings growth for AMPH?
- Looking at Amphastar's growth, its revenue over the trailing twelve months (TTM) was $731M. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.80%, and quarterly earnings saw a YoY growth of -41.40%.
- How much of AMPH stock is held by insiders and institutions?
- Wondering who owns Amphastar stock? Company insiders (like executives and directors) hold about 23.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 72.85%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.